Press releaseGlobe Newswire
Aligos Therapeutics
ALGS · NASDAQ
$5.03+$0.19 (+3.93%)TodayMarket closed ·
Prev close $4.84
Latest news
- NewsAvi Kapoor
Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
- Press releaseGlobe Newswire
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- Press releaseGlobe Newswire
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026
- Press releaseGlobe Newswire
Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection
- NewsTanya Rawat
Aligos Therapeutics Stock Is Trending Overnight: Here's What's Going On With ALGS Stock
- News
Aligos Therapeutics Receives Upfront Payment Of $25M From Exclusive License Deal Of Pevifoscorvir Sodium In Greater China With Xiamen Amoytop; Pevifoscorvir Granted Breakthrough Therapy Designation
- Press releaseGlobe Newswire
Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
- Press releaseGlobe Newswire
Aligos Therapeutics Presents Positive Data at the EASL Congress 2026
- NewsVandana Singh
Aligos Therapeutics Says China Pact Puts HBV Drug In Focus Amid Trial Updates
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
Market-Moving News for April 16th
- News
Aligos Therapeutics Earnings Report: Q4 Overview
- News
Earnings Scheduled For March 5, 2026
- News
A Peek at Aligos Therapeutics's Future Earnings
- News
Earnings Scheduled For November 6, 2025
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
Aligos Therapeutics Q2 EPS $(1.53) Beats $(2.36) Estimate, Sales $965.00K Beat $433.33K Estimate
- News
Earnings Scheduled For August 6, 2025
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- NewsErica Kollmann
Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday?
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.